Sicriptin 1.25mg tablet contains an active component as Bromocriptine. It is a medication used to treat various medical conditions. It belongs to a class of drugs known as dopamine agonists, activating certain dopamine receptors in the brain. Dopamine is a neurotransmitter, and its regulation is essential for several physiological functions. It is primarily used to treat conditions characterized by elevated levels of the hormone prolactin in the blood (hyperprolactinemia). High prolactin levels can cause various issues, including infertility, irregular menstrual periods, and milk production in non-pregnant women. Additionally, it is used as an adjunct therapy for Parkinson's disease, improving motor symptoms by activating dopamine receptors. Sicriptin 1.25mg tablet can also be part of the treatment for acromegaly, a condition resulting from excess growth hormone production. In emergencies, this medication can manage neuroleptic malignant syndrome, a rare and potentially life-threatening condition associated with certain antipsychotic medications. Although not a primary diabetes medication, It has been used off-label to improve glycemic control in patients with type 2 diabetes potentially. Individuals with known hypersensitivity or allergy to Sicriptin 1.25mg tablet or any of its components should not take this medication. This medication can cause changes in blood pressure, and it is contraindicated in individuals with uncontrolled hypertension (high blood pressure). This medication is contraindicated in individuals with postpartum hypertension or a history of toxemia of pregnancy. Patients with a history of cardiovascular disorders, including angina, myocardial infarction, or peripheral vascular disease, should use Sicriptin 1.25mg tablet with caution due to potential effects on blood pressure. This medication can affect the central nervous system and may exacerbate certain psychiatric conditions. Caution is needed when prescribing this medication to individuals with a history of psychiatric disorders.